Isabel Morgado, PhD

Dr. Isabel Morgado is working as a Scientist I at Nurix Therapeutics. She received her Ph.D. in Molecular Biology from the University of Algarve in Portugal, where she studied the structure-to-function evaluation and amyloid formation by the protein transthyretin. Since then, her research interest has focused on protein misfolding and amyloid diseases. Dr. Isabel Morgado was a DFG fellow at the Max Planck Research Unit for Protein Folding, studying Ab amyloid formation, and a Marie Curie fellow at the Center of Marine Sciences of Algarve and Boston University, investigating transthyretin and apolipoprotein A-I amyloidosis.

Previously, Dr. Isabel Morgado worked as an Instructor at Stanford and Dr. Liao's lab to uncover mechanisms of amyloid diseases, in particular transthyretin cardiac amyloidosis, using in vivo zebrafish models.